A new multidrug resistance protein at the blood-brain barrier.
about
Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.Methods to assess drug permeability across the blood-brain barrier.Development of neuropeptide drugs that cross the blood-brain barrier.Expression and function of multidrug resistance transporters at the blood-brain barriers.Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.How does the benzamide antipsychotic amisulpride get into the brain?--An in vitro approach comparing amisulpride with clozapine.Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics.17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity.Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters.Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team upABC Transporters and the Alzheimer's Disease Enigma.Role of the breast cancer resistance protein (ABCG2) in drug transport.Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.Breast cancer resistance protein in pharmacokinetics and drug-drug interactions.Blood-brain barrier and chemotherapeutic treatment of brain tumors.Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice.Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated ratsDelivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.Moving out: from sterol transport to drug resistance - the ABCG subfamily of efflux pumps.The right compound in the right assay at the right time: an integrated discovery DMPK strategy.Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.Efflux proteins at the blood-brain barrier: review and bioinformatics analysis.Investigation of the functional single-nucleotide polymorphisms in the BCRP transporter and susceptibility to colorectal cancer.The effect of acute administration of rifampicin and imatinib on the enterohepatic transport of rosuvastatin in vivo.The C3435T polymorphism of MDR1 and susceptibility to adult glioma.Drug Transport at the Brain and Endothelial Dysfunction in Preeclampsia: Implications and Perspectives
P2860
Q30768284-A777108D-EB0D-4712-865C-BE36B5229401Q31034258-166DFAC3-FB7A-4BA6-9443-82268F95FC9BQ33569277-59B55B53-895C-47D0-A5A4-E3A30F1BF845Q33998841-F19F966B-BFF1-4179-96C6-658447D59C08Q34035224-FE7BCB0D-38A2-447B-AEC8-C8D1A171E048Q34214692-72B51ECE-922E-46FA-BBFE-41F98123DC10Q34444082-79723C6D-A25F-4E03-81E4-628883832867Q34502756-0E4444B7-927F-4A6F-AE02-619A429BBE57Q35141800-C6F8C812-98B8-4ED6-A354-10BC6D6B82D5Q35720625-9E6584F0-D81B-4770-95D5-BCD6EDC39B7BQ36005085-B6CCE85D-DEFE-49F4-BBF8-9CA029B72B82Q36250753-8F155C22-0B54-41C2-8231-E117AD14444CQ36525551-58FC2CF9-ECA5-4051-84C1-57D6AF588BDDQ36544862-765D9AAF-0913-4E69-9A7E-E222296CE732Q36558683-A5E321DF-A087-43E0-A2C2-B8E4CF12BD57Q37143617-4AEF60D3-BEE8-455B-86AF-823F73D4F7B6Q37151581-6A6126E2-C953-4D1D-B0FD-5798B2771324Q37308322-F8C55C9A-6009-4D47-AD98-D9429A0C3A76Q37855817-2ED309DA-C507-4AFF-BB03-4CFEB63381A4Q37937572-B8BED851-912C-4210-8A07-7389CBA45882Q38018653-B3405AEF-564E-49AB-918E-9C198399E82FQ38117056-A1AD35B9-24F8-423C-AAE6-D933FD4FA879Q38260539-7A9CD973-DD8C-49FC-8BD3-9A0B1A643F2BQ38730069-58DA1A90-105F-47AA-9A75-9D87DAFECA2DQ39290800-C07FB429-9507-4B72-B9A1-336A124FFACCQ42177504-53E4C3A9-86E4-44B7-91A2-DB5E045B8A41Q43003337-7696474C-1F95-428A-8C48-0DB91B2FEC40Q48860346-674D2FD6-07F8-43A4-9C63-A665B8DA005CQ59136492-1AA55707-162E-4D64-89EC-C9356BB56E48
P2860
A new multidrug resistance protein at the blood-brain barrier.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A new multidrug resistance protein at the blood-brain barrier.
@ast
A new multidrug resistance protein at the blood-brain barrier.
@en
type
label
A new multidrug resistance protein at the blood-brain barrier.
@ast
A new multidrug resistance protein at the blood-brain barrier.
@en
prefLabel
A new multidrug resistance protein at the blood-brain barrier.
@ast
A new multidrug resistance protein at the blood-brain barrier.
@en
P1476
A new multidrug resistance protein at the blood-brain barrier.
@en
P2093
Hans-Joachim Galla
Tanja Eisenblätter
P304
P356
10.1016/S0006-291X(02)00376-5
P407
P577
2002-05-01T00:00:00Z